Viewing Study NCT03313661


Ignite Creation Date: 2025-12-24 @ 11:49 AM
Ignite Modification Date: 2026-04-23 @ 5:00 AM
Study NCT ID: NCT03313661
Status: UNKNOWN
Last Update Posted: 2018-08-27
First Post: 2017-10-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Co-administration of Cabergoline and Gliclazide Improve Glycemic Parameters and Lipid Profile in T2DM Patients
Sponsor: Sherief Abd-Elsalam
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module